These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16610809)

  • 21. Synthesis of functionalized cinnamaldehyde derivatives by an oxidative Heck reaction and their use as starting materials for preparation of Mycobacterium tuberculosis 1-deoxy-D-xylulose-5-phosphate reductoisomerase inhibitors.
    Nordqvist A; Björkelid C; Andaloussi M; Jansson AM; Mowbray SL; Karlén A; Larhed M
    J Org Chem; 2011 Nov; 76(21):8986-98. PubMed ID: 21936546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. α,α-Difluorophosphonohydroxamic Acid Derivatives among the Best Antibacterial Fosmidomycin Analogues.
    Dreneau A; Krebs FS; Munier M; Ngov C; Tritsch D; Lièvremont D; Rohmer M; Grosdemange-Billiard C
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal structure of 1-deoxy-d-xylulose 5-phosphate reductoisomerase from the hyperthermophile Thermotoga maritima for insights into the coordination of conformational changes and an inhibitor binding.
    Takenoya M; Ohtaki A; Noguchi K; Endo K; Sasaki Y; Ohsawa K; Yajima S; Yohda M
    J Struct Biol; 2010 Jun; 170(3):532-9. PubMed ID: 20353826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel reverse thia-analogs of fosmidomycin: Synthesis and antiplasmodial activity.
    Lienau C; Gräwert T; Alves Avelar LA; Illarionov B; Held J; Knaab TC; Lungerich B; van Geelen L; Meier D; Geissler S; Cynis H; Riederer U; Buchholz M; Kalscheuer R; Bacher A; Mordmüller B; Fischer M; Kurz T
    Eur J Med Chem; 2019 Nov; 181():111555. PubMed ID: 31382119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IspC as target for antiinfective drug discovery: synthesis, enantiomeric separation, and structural biology of fosmidomycin thia isosters.
    Kunfermann A; Lienau C; Illarionov B; Held J; Gräwert T; Behrendt CT; Werner P; Hähn S; Eisenreich W; Riederer U; Mordmüller B; Bacher A; Fischer M; Groll M; Kurz T
    J Med Chem; 2013 Oct; 56(20):8151-62. PubMed ID: 24032981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MEPicides: α,β-Unsaturated Fosmidomycin Analogues as DXR Inhibitors against Malaria.
    Wang X; Edwards RL; Ball H; Johnson C; Haymond A; Girma M; Manikkam M; Brothers RC; McKay KT; Arnett SD; Osbourn DM; Alvarez S; Boshoff HI; Meyers MJ; Couch RD; Odom John AR; Dowd CS
    J Med Chem; 2018 Oct; 61(19):8847-8858. PubMed ID: 30192536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-acylated sulfonamide congeners of fosmidomycin lack any inhibitory activity against DXR.
    Gadakh B; Pouyez J; Wouters J; Venkatesham A; Cos P; Van Aerschot A
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1577-9. PubMed ID: 25726328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological evaluation of phosphate isosters of fosmidomycin and analogs as inhibitors of Escherichia coli and Mycobacterium smegmatis 1-deoxyxylulose 5-phosphate reductoisomerases.
    Munier M; Tritsch D; Krebs F; Esque J; Hemmerlin A; Rohmer M; Stote RH; Grosdemange-Billiard C
    Bioorg Med Chem; 2017 Jan; 25(2):684-689. PubMed ID: 27955925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modifications around the hydroxamic acid chelating group of fosmidomycin, an inhibitor of the metalloenzyme 1-deoxyxylulose 5-phosphate reductoisomerase (DXR).
    Zinglé C; Kuntz L; Tritsch D; Grosdemange-Billiard C; Rohmer M
    Bioorg Med Chem Lett; 2012 Nov; 22(21):6563-7. PubMed ID: 23025997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A second target of the antimalarial and antibacterial agent fosmidomycin revealed by cellular metabolic profiling.
    Zhang B; Watts KM; Hodge D; Kemp LM; Hunstad DA; Hicks LM; Odom AR
    Biochemistry; 2011 May; 50(17):3570-7. PubMed ID: 21438569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prodrugs of reverse fosmidomycin analogues.
    Brücher K; Gräwert T; Konzuch S; Held J; Lienau C; Behrendt C; Illarionov B; Maes L; Bacher A; Wittlin S; Mordmüller B; Fischer M; Kurz T
    J Med Chem; 2015 Feb; 58(4):2025-35. PubMed ID: 25633870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The malarial drug target Plasmodium falciparum 1-deoxy-D-xylulose-5-phosphate reductoisomerase (PfDXR): development of a 3-D model for identification of novel, structural and functional features and for inhibitor screening.
    Goble JL; Adendorff MR; de Beer TA; Stephens LL; Blatch GL
    Protein Pept Lett; 2010 Jan; 17(1):109-20. PubMed ID: 20214634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of in vitro antibacterial activity of fosmidomycin and its derivatives].
    Shtannikov AV; Sergeeva EE; Biketov SF; Ostrovskiĭ DN
    Antibiot Khimioter; 2007; 52(7-8):3-9. PubMed ID: 18986018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and evaluation of alpha-halogenated analogues of 3-(acetylhydroxyamino)propylphosphonic acid (FR900098) as antimalarials.
    Verbrugghen T; Cos P; Maes L; Van Calenbergh S
    J Med Chem; 2010 Jul; 53(14):5342-6. PubMed ID: 20568776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibacterial and antitubercular activity of fosmidomycin, FR900098, and their lipophilic analogs.
    Uh E; Jackson ER; San Jose G; Maddox M; Lee RE; Lee RE; Boshoff HI; Dowd CS
    Bioorg Med Chem Lett; 2011 Dec; 21(23):6973-6. PubMed ID: 22024034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth medium-dependent antimicrobial activity of early stage MEP pathway inhibitors.
    Sanders S; Bartee D; Harrison MJ; Phillips PD; Koppisch AT; Freel Meyers CL
    PLoS One; 2018; 13(5):e0197638. PubMed ID: 29771999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and antimalarial evaluation of prodrugs of novel fosmidomycin analogues.
    Faísca Phillips AM; Nogueira F; Murtinheira F; Barros MT
    Bioorg Med Chem Lett; 2015; 25(10):2112-6. PubMed ID: 25881827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitors of the herbicidal target IspD: allosteric site binding.
    Witschel MC; Höffken HW; Seet M; Parra L; Mietzner T; Thater F; Niggeweg R; Röhl F; Illarionov B; Rohdich F; Kaiser J; Fischer M; Bacher A; Diederich F
    Angew Chem Int Ed Engl; 2011 Aug; 50(34):7931-5. PubMed ID: 21766403
    [No Abstract]   [Full Text] [Related]  

  • 39. Synthesis and Antiplasmodial Activity of Novel Fosmidomycin Derivatives and Conjugates with Artemisinin and Aminochloroquinoline.
    Palla D; Antoniou AI; Baltas M; Menendez C; Grellier P; Mouray E; Athanassopoulos CM
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33096817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In silico identification of promiscuous scaffolds as potential inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase for treatment of Falciparum malaria.
    Wadood A; Ghufran M; Hassan SF; Khan H; Azam SS; Rashid U
    Pharm Biol; 2017 Dec; 55(1):19-32. PubMed ID: 27650666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.